课题基金 / 基金详情

Understanding early life determinants and mechanisms to preventing life course multimorbidity

Understanding early life determinants and mechanisms to preventing life course multimorbidity
了解早期生命决定因素和预防生命历程多重疾病的机制
批准号:
MR/V004883/1
负责人:
Niina Kolehmainen
金额:
$12.65万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

Niina Kolehmainen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The early part of life-from tiny embryo, to baby in the womb, to birth, through infancy and early childhood-is a time when many events happen that can have important, lasting effects on our lives. We want to find ways to make these early parts of our lives as good as they can be, so that we enter adulthood healthy and able to cope well with things that life may throw at us.Our research will investigate the early life events that affect our hearts, blood vessels, mental health, and metabolism (how our bodies convert food to energy and to building blocks such as proteins, and eliminate waste). We want to find ways to prevent early life events that lead us to have several health problems in later life. We call this "multi-morbidity", meaning two or more long-term conditions or disabilities.The idea of looking at health from early life into adulthood has been around for a while, but it is still fairly rare to actually link information from early life events with multimorbidity. We are a new group of people with complementary expertise in early life and adult health. For example, we have lab scientists studying hearts and blood vessels; psychologists investigating how movement and physical activity affects mothers and children; children's doctors providing front line care while also researching the best ways to help their patients; a data engineer; and public health researchers working on studies that follow people's health for decades. We know that to answer the big questions about early life events and multimorbidity we need to collaborate in new ways across our areas of expertise. We are now proposing a 6-month project to bring together what we know and our different techniques ('methods'), and to refine our bigger 4-year plan. Our bigger plan has four related parts:A. We will find and make sense of different types of existing evidence about early life drivers of multimorbidity. We will work with stakeholders (parents, carers, children, policy makers, professionals) to draw up a map that will help people to think more clearly about early life events that cause or prevent multimorbidity, see the gaps in our knowledge, and decide which questions to answer next.B. To answer these questions, we will electronically link up existing UK-based data (e.g. heel prick samples, red book questions) and use new methods, such as artificial intelligence, to explore it. We will also collect new data to fill gaps.C. As the data helps us better understand early life events and how they affect later health, we will co-design new 'interventions' to alter these events. For example, we may develop medicines, health monitors, or ways for people to do things differently. They may be for individuals or populations.D. We will involve patients and the public throughout to ensure focus on what matters and that the interventions work well in real life.In the initial 6 months, we will use three particular areas to pilot our ideas and techniques. These are areas where: early life events are already known to affect later life multimorbidity but how this happens is not clear; there is great potential for better interventions; and we have substantial expertise. The areas are:- mother's heart and blood vessel health, and influence on baby- stressful events for the mother/child, and effects on hormones and later child health- mother/child movement and physical activity, and effects on mother/child heart and blood health and stressThis research will change the way health and care is provided, moving from diagnosing and treating individual conditions as they appear to intervening on early life psychological, social and medical issues. This will prevent multiple problems later in life for large numbers of people. This will improve child and parent health, and reduce the burden on families and services. This research will also help inform what information is important for governments to collect in early life to monitor public health.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Group, The Child Routine Data (2021): Making a difference for children, young people and families' lives in the North East: Recommendations for the next steps In using routinely collected data
小组,《儿童常规数据》(2021 年):为东北部儿童、青少年和家庭的生活带来改变:对使用常规收集数据的后续步骤的建议
DOI: --
发表时间: 2021
期刊:
影响因子: --
作者: [Child Data Group]
通讯作者: Child Data Group
DOI: 10.1136/bmjpo-2022-001537
发表时间: 2022-10
期刊: BMJ paediatrics open
影响因子: 2.6
作者: []
通讯作者:
DOI: 10.1177/14703572221092410
发表时间: 2022-08
期刊: VISUAL COMMUNICATION
影响因子: 1.5
作者: [Robson, Ian]
通讯作者: Robson, Ian
Participation in physical leisure pursuits and play in children with motor impairments: developing a theory- and evidenc
  • 批准号:
    G0902129/2
  • 项目类别:
    Fellowship
  • 资助金额:
    $11.12万
  • 财政年份:
    2013
  • 负责人:
    Niina Kolehmainen
  • 依托单位:
Participation in physical leisure pursuits and play in children with motor impairments: developing a theory- and evidenc
  • 批准号:
    G0902129/1
  • 项目类别:
    Fellowship
  • 资助金额:
    $38.82万
  • 财政年份:
    2010
  • 负责人:
    Niina Kolehmainen
  • 依托单位:
国内基金
海外基金
Crocin 抑制 Hartley 豚鼠早期骨关节炎发生的 作用机制研究
RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
  • 批准号:
    82372167
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    江继宏
  • 依托单位:
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
  • 批准号:
    82372089
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    李万万
  • 依托单位:
环境抗雄激素干预AR/TGFB1I1致尿道下裂血管内皮细胞发育异常的机制及其“预警信号”在早期诊断中的价值
  • 批准号:
    82371605
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    蒋君涛
  • 依托单位: